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Abstract: Microarray technologies are state of the art in biological research, which 
requires fast genome, proteome and transcriptome analysis technologies. Often antibodies 
are applied in protein microarrays as proteomic tools. Since the generation of antibodies 
against toxic targets or small molecules including organic compounds remains challenging 
the use of antibodies may be limited in this context. In contrast to this, aptamer 
microarrays provide alternative techniques to circumvent these limitations. In this article 
we review the latest developments in aptamer microarray technology. We discuss 
similarities and differences between DNA and aptamer microarrays and shed light on the 
post synthesis immobilization of aptamers including corresponding effects on the 
microarray performance. Finally, we highlight current limitations and future prospects of 
aptamer microarray technology. 
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1. Introduction 
Aptamers are single-stranded oligonucleotides. Depending on their sequence, the temperature, pH 
and the presence of certain ions they fold into defined three-dimensional (3D) structures. When 
properly folded, these aptamers are able to bind other molecules (targets) with high affinity and 
specificity. Hydrogen bonding, hydrophobic and electrostatic interactions are the major chemical 
interactions, which lead to the high affinity of the aptamers to their respective targets [1,2]. 
Furthermore, the molecular recognition of aptamers is highly specific.  
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Aptamers are isolated via an in vitro selection process, which is called systematic evolution of 
ligands by exponential Enrichment (SELEX). A library containing 1014 to 1015 different randomized 
oligonucleotides is incubated with the target. Afterwards, unbound oligonucleotides are separated from 
the binding aptamer candidates. After amplification via PCR, the antisense strand is removed and the 
propagated aptamer candidates are subjected to the next round of selection and amplification. Usually, 
aptamer candidates have to compete for a limited amount of target. Therefore, aptamer candidates with 
low affinity are consecutively removed from the selection pool resulting in isolation of binders with 
high affinity after 6–12 SELEX rounds. Detailed reviews of the SELEX process, numerous 
improvements and variants of SELEX processes can be found elsewhere [3,4]. 
In comparison to antibodies, which are conventionally used in applications that require affinity 
ligands, aptamers feature comparable affinities and specificities. Beside this, aptamers are isolated and 
produced via in vitro operations and therefore exhibit low batch-to-batch variations. Furthermore, 
aptamers are long-term stable, even at elevated temperatures. These features make aptamers valuable 
affinity ligands which can be applied in several technologies including affinity chromatography [5], 
sensor platforms [6,7], and microarrays [8]. In this review we focus on aptamer microarray technology.  
2. Aptamer Microarrays 
2.1. Conventional Microarrays vs. Aptamer Microarrays 
Classic DNA microarrays are used to measure mRNA levels thereby performing transcriptome 
analysis. In the initial step of a microarray experiment, the isolated mRNA is transcribed into cDNA, 
which is then fluorescently labeled and purified. The labeled antisense-orientated cDNA is then 
transferred to a microarray slide bearing immobilized complementary sense-orientated DNA 
oligonucleotide probes. Upon approaching the appropriate probe the cDNA hybridizes to this probe 
and is therefore immobilized. After the incubation, unbound cDNA is washed away and the relative 
frequency of remaining cDNA is estimated by measuring the fluorescence intensity of the features. 
In complementary approaches protein microarrays allow the detection and quantification of 
proteins, which are the actual protagonists within living organisms. Protein microarrays are dominated 
by antibody microarrays, and are especially successful in the sandwich format. Immobilized antibodies 
capture their corresponding antigen, which is than detected by binding of a second fluorescently 
labeled detection antibody directed against a different epitope of the same antigen. Although these 
antibody-based microarrays allow for ELISA-like detection of proteins in a multiplexed setup, there 
are still some limitations associated with this type of assay. Antibodies possess a rather low stability, 
resulting in limited shelf life and the need for cooled storage. Moreover, due to the development of 
antibodies in living organisms by immunization, not all antigens can be readily applied for antibody 
generation. This is especially true for small molecules, toxic substances and substances that are not 
able to provoke an immune response. 
A suitable technology to overcome the limitations of protein/antibody microarrays is the aptamer 
microarray technology, which uses the advantages of DNA microarrays. Here, aptamers are 
immobilized on the microarray surface and serve as probes for various substances. As aptamers are 
also composed of nucleotides, well-known techniques for DNA microarray manufacturing can be used 
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to produce aptamer microarrays. However, simply applying strategies of DNA microarrays to aptamer 
microarrays may not lead to adequate results. This discrepancy is a consequence of some special 
features of aptamers, which differ significantly from conventional DNA. 
DNA microarrays are optimized for best possible DNA-DNA interaction. In contrast, aptamer 
microarrays not only consist of oligonucleotides, but also of analytes, which may be proteins or small 
molecules. These molecules can interact with other components than the aptamer (e.g., microarray 
surface). As a consequence, this may result in a high background signal which is lowering the 
performance of the aptamer microarray [9,10]. Surface properties can be adapted to this new 
requirement by applying suitable modifications. For example a PEGylation can be performed to reduce 
the unspecific binding of proteins to the surface [11,12]. The resulting coated surface is termed an 
antifouling matrix. 
In contrast to “simple” base pairing of DNA strands, aptamers require a specific structure to bind 
their targets. Usually aptamers are able to fold into these defined 3D structures. However, the folding 
of an aptamer may be affected by aptamer immobilization, which can lead to a loss of functionality. 
Therefore it is much more difficult to optimize aptamer microarrays, and some general aspects have to 
be considered when developing an aptamer microarray. These aspects are elaborated in the 
following subsections. 
2.2. Strategies for Aptamer Microarray Fabrication 
Aptamer microarray fabrication techniques can be classified into two categories. On the one hand 
the aptamers can be synthesized directly on the microarray’s surface by in situ synthesis. This 
approach requires sophisticated synthesis machinery and is often used in serial production of 
commercial microarrays. However, there are some limitations, which arise when fabricating an 
aptamer microarray via in situ synthesis.  
In situ synthesis yields in ready-to-use microarrays, therefore a post synthesis purification of 
aptamers is not possible. As a consequence, common synthesis procedures limit the aptamer length to 
50 nt as for longer strands the given yield of full length aptamer is decreasing significantly [13]. In 
addition, aptamers may only be immobilized at their 3' terminus as oligonucleotides are synthesized 
from 3' to 5' and reverse synthesis direction is not established yet. Furthermore, single mutations 
within the aptamer sequence may lead to a full loss of function. Therefore, sequence fidelity is the 
most important parameter of in situ synthesis for aptamers [9]. More detailed information on in situ 
synthesis of aptamers (and oligonucleotides in general) can be found elsewhere [14]. 
On the other hand aptamers can be attached to the microarray after their synthesis and purification, 
so called post synthesis immobilization, on which we will focus in this section. Different strategies 
have been developed for the post synthesis approach. Usually, dissolved aptamers are spotted onto the 
microarray surface via contact or non-contact printing. Here, functionalized microarray substrates and 
modified aptamers are required to attach the aptamers to the surface.  
2.3. Attachment Chemistries for Post Synthesis Immobilization 
One possibility for aptamer immobilization is exploiting the streptavidin biotin interaction. In this 
case the microarray surface is coated with streptavidin and aptamers are labeled with biotin. When 
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spotted on the array surface the biotin forms a stable complex with streptavidin and the aptamer is 
thereby immobilized. As the dissociation constant of the streptavidin-biotin complex is very low 
(10−15 M), and the complex is kinetically stable [15], this approach offers a fast, reliable and simple 
immobilization of biotinylated aptamers. Unfortunately streptavidin, like any other protein, can 
undergo denaturation. Therefore, aptamer microarrays based on streptavidin-coated slides degenerate 
over time even in chilled storage. 
To avoid this shortcoming and to produce microarrays taking advantage of the high stability of 
aptamers, aptamers can also be covalently immobilized directly on the microarray surface, which is 
usually a modified glass or polymer slide (see Figure 1 for the most common microarray 
modifications). Microarrays of this type can be stored at room temperature and are usually stable for 
several years. For the attachment of aptamers, different coupling chemistries have been developed. 
The attachment chemistries described in the following display only a fraction of the diverse 
immobilization chemistries that are available. A more comprehensive review has been published by 
Balamurugan et al. [16]. 
 
Figure 1. Different microarray surface modifications for aptamer immobilization. 
Often simple chemical groups such as hydroxyl, carboxyl or amine are provided on the 
microarray’s surface. To allow immobilization of aptamers on these surfaces, aptamers can already be 
functionalized with different modifications during their synthesis. Conventionally amine or thiol 
modifications are utilized to immobilize oligonucleotides. The immobilization is often initialized by 
the addition of an auxiliary. Some slides are already activated by their manufacturers, so they do not 
need an auxiliary but are often sensitive to humidity. 
The most basic type of surface function is the hydroxyl group. These slides allow the customers to 
apply their own surface chemistries. Often these slides are activated with carbonyldiimidazole 
(CDI) [17]. The formed carbamate is then attacked by a nucleophile, (amine or thiol group of modified 
aptamer) forming a covalent bond between the surface and the aptamer.  
A common way to attach aptamers to a carboxyl-modified microarray surfaces is to activate the 
surface with 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and stabilize the intermediate 
with N-Hydroxysuccinimide (NHS). The resulting NHS ester is then reacting with an amine-modified 
aptamer to form a stable amide, which is connecting the aptamer to the microarray surface. The 
reaction can also be performed without using NHS. In that case, the formed intermediate is directly 
attacked by the amine-modified aptamer. This approach is not as efficient as using NHS, because the 
intermediate may also be hydrolyzed. When using NHS, the intermediate is transformed into a more 
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stable NHS ester. The NHS ester is also subjected to hydrolysis but has a longer shelf life and 
therefore yields in higher immobilization efficiency [18–20]. Some manufacturers offer NHS activated 
slides in a hermetic sealing (e.g., Schott; Arrayit; PolyAn). 
Amine-modified microarray substrates can be activated using p-Phenylene diisothiocyanate 
(PDITC). On the microarray, this symmetrical linker forms a thiourea structure. The remaining 
isothiocynanate group can react with another nucleophile such as an amine or thiol. Furthermore, 
thiolated aptamers can be attached to amine-modified surfaces using Sulfosuccinimidyl-4-(N-
maleimidomethyl)cyclohexane-1-carboxylate (Sulfo-SMCC). On one site, this crosslinker bears an 
NHS ester, which is used to couple the molecule onto the amine-modified microarray surface. On the 
other site, the thiolated aptamer can react with the maleimide group in a thiol-Michael addition. 
Microarray slides with maleimide-activated esters are commercially available but should be used directly 
after the hermitic sealing is opened because the maleimide ester is susceptible to hydrolysis [21]. 
Another way to attach aptamers to amine-modified surfaces is using glutaraldehyde as a symmetrical 
linker. Together with the surface amine, glutaraldehyde forms an imine bond. The second aldehyde 
group reacts with an amine-modified aptamer in the same way. The imines should be reduced to 
amines with sodium borohydride or other reducing agents to improve the stability [22]. This principle 
can be transferred to attach amine-modified aptamers to an aldehyde-bearing surface.  
Some manufacturers produce microarray slides with an epoxy-modified surface. Here, aptamers can 
be attached utilizing an amine or thiol modification, which reacts with the epoxy group via 
nucleophilic ring opening. This reaction does not require any auxiliary. Epoxy-modified microarrays 
are more stable to hydrolysis and have a longer shelf life than NHS ester-activated or PDITC activated 
microarray substrates. 
A relatively new option for aptamer immobilization is the copper(I)-catalyzed azide-alkyne 
cycloaddition (CuAAC), a “click” reaction [23,24]. In this reaction an alkyne reacts with an azide 
forming a 1,2,3-triazole ring with respective ligands. For this approach the surface modification can 
either be azide or the alkyne, as aptamers can already be modified with either azides or alkynes. This 
approach features high immobilization efficiency and simple reaction conditions. However, up until 
now, only very few suppliers offer such surface modifications for microarrays. 
Aptamers can also be immobilized on gold-coated surfaces. First, the aptamers are thiolated. Then, 
the thiol-group interacts with the gold surface via sulfur gold interaction resulting in immobilization of 
the aptamers on the surface. Nucleic acids can also stick to the surface by interaction of gold with the 
nitrogen side functions of the nucleobases [25]. Therefore, a second thiol-modified substance is often 
applied to substitute the adsorbed nitrogen from the gold surface, as the affinity of thiols to gold is 
higher than the affinity of nitrogen derivates [16].  
2.4. Steric Requirements of Aptamers 
Aptamers have certain steric requirements to attain their proper folding. These steric requirements 
can be challenged by different parameters during aptamer microarray production, which are discussed 
in the following. 
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2.4.1. Surface Density 
The surface density of the immobilized aptamers is an important parameter affecting aptamer 
microarray performance. If the surface density is low, this will result in a low signal from the feature 
and a limited dynamic range of the microarray. In contrast, if the surface density is too high, steric 
hindrance is suggested to cause problems in aptamer folding and therefore in subsequent binding of the 
target [26,27]. This will again result in a low signal. 
One parameter that defines the microarray surface density is the loading capacity of the microarray 
surface. Different microarray substrates feature different loading capacities. In general, planar surfaces 
show a rather limited loading capacity. By applying a 3D layer onto the microarray surface, the 
available surface area is greatly enhanced, which yields in a higher loading capacity. However, 3D 
microarray substrates tend to exhibit higher background fluorescence [28].  
The surface density is not only dependent on the loading capacity, but also on the spotting 
concentration of the aptamer and the immobilization efficiency. Consequently, the aptamer density can 
be easily controlled via variation of the aptamer concentration. Moreover, print buffers and additives 
within the print buffers may affect the immobilization efficiency [29]. 
2.4.2. Surface Charge 
Oligonucleotides are negatively charged and tend to stick to positively charged surfaces. This 
electrostatic interaction interferes with the proper folding of the immobilized aptamer and may lead to 
a loss of functionality. The surface charge can be reversed by capping the surface with a negatively 
charged agent [30] resulting in a repulsion of the aptamers by the capped surface. On the other hand, 
many aptamers require divalent ions (e.g., magnesia, calcium) for their correct folding. These ions can 
mediate electrostatic interactions between a negatively charged surface and the aptamers nucleotides [31]. 
2.4.3. Proximity to Surface and Spacers 
Steric requirements of aptamers may be challenged if the aptamers are immobilized too close to the 
microarray’s surface [30]. This effect varies for each aptamer and has to be investigated empirically. 
While some aptamers stay functional when directly attached to the surface, others undergo significant 
conformal changes and lose their functionality. Furthermore, the orientation in which the aptamer is 
immobilized affects the folding of the aptamer. Again there are aptamers that stay functional when 
immobilized via either 5' or 3' terminus and there are aptamers, which lose their function when 
immobilized via the “wrong” terminus. There are also cases in which an aptamer loses its function 
independent from the orientation in which it is immobilized. No general rule can be given for the best 
strategy to immobilize aptamers in a functional state, but to investigate these parameters for each 
aptamer individually.  
To overcome problems in aptamer folding caused by surface proximity, molecular spacers are often 
inserted between the aptamer and the microarray surface. These spacers bear a reactive group, which is 
used to couple the aptamer onto the surface. When attached to the microarray, the spacer spans a 
certain distance allowing the aptamer to fold correctly.  
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Usually linear spacers such as poly(dT) or carbon chains are attached to the aptamer before 
immobilization. Also some polymers like polyethylene glycol or polyethylene imine have been used to 
immobilize aptamers. Table 1 gives an overview over the properties of the most common spacer types 
for aptamer immobilization. 
Table 1. Different spacer types applied for aptamer immobilization and their basic properties. 
Spacer type Abbreviation Length/unit [angstrom] Hydrophobicity 
Aliphatic carbon chain C 1.57 [32] Hydrophobic 
Polyethylene glycol  PEG 3.51 [33]  Hydrophilic 
Polyethylene imine  PEI 2.9–3.5 [34] Hydrophilic 
Poly thymine  poly(dT) 3.4 [35] Hydrophilic 
 
To simultaneously enhance the loading capacity of the surface and the distance between aptamer 
and the microarray surface, nonlinear, branched spacers or dendrimers can be applied to immobilize 
aptamers. Once attached to the surface, these molecules show multiple sites for aptamer immobilization. 
As simple as the idea of using a spacer may be, there are several effects that may occur when using 
a spacer within aptamer microarrays. Even though long spacers are used to immobilize aptamers, they 
may not remain fully functional when immobilized. The correct folding of the aptamer can be 
suppressed by the spacer itself due to steric hindrance or other interactions with the aptamer. If a long 
spacer is applied, this spacer may be irregularly folded itself, which again could challenge the steric 
requirements of the corresponding aptamer [36].  
Again, the spacer position within the aptamer has a significant effect on the folding and function of 
an aptamer. The strength of this effect differs from aptamer to aptamer [10,27,30,36]. However, the 
preferred orientation of an aptamer may be predicted by atomic scale calculation [37]. Similar effects 
on the folding of an aptamer can also be observed when introducing other modifications like 
fluorescent dyes to an aptamer [8]. 
A spacer may also affect the efficiency of aptamer immobilization. Edwards et al. claimed that 
elongated poly(dT) spacers lower the immobilization efficiency, possibly due to a charge barrier [27]. 
On the other hand this reduced immobilization efficiency may leave more space for the aptamers to 
fold into their active structure and therefore result in a higher ratio of functional aptamers in the 
feature [35].  
2.5. Assay Formats 
Aptamer microarrays can be performed in different formats (phases), see Figure 2. A literature 
overview is given in Table 2. 
 
Figure 2. Schematic overview over different aptamer microarray formats. 
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2.5.1. Forward Phase 
In a forward phase microarray, the recognition element, namely the aptamer, is immobilized on the 
surface. At the beginning of incubation the analytes are free in solution; later, they are captured by the 
aptamer. Except for label-free detection techniques like SPR, in this assay format the analyte has to be 
labeled, which may interfere with subsequent analyte capture by the aptamer [10]. Moreover, if 
components in the sample form complexes with the target, these complexes may be detected at the 
specific feature. As the non target compounds also increase the given signal from the feature, this leads 
to an overestimation of the target concentration and therefore to false results in a forward phase 
microarray [38].  
By immobilizing more than one aptamer on the aptamer microarray, a forward phase microarray 
can give insight into many conditions within a single sample. When analyzing more samples, 
additional microarrays have to be performed. However, by partitioning the microarray into subarrays 
several samples can be investigated in parallel (e.g., by using the 16 pad format). 
2.5.2. Reverse Phase 
In contrast to the forward phase microarray, in a reverse phase microarray, the analyte is 
immobilized on the microarray surface. This immobilization can either be based on adsorptive 
interactions or covalent attachment. An aptamer is used to detect the analyte within the sample.  
A highly parallel detection of the same analyte in different samples is possible when immobilizing 
these samples on the same slide. 
This approach has mainly been applied to proteins, which then is called a reverse phase protein 
microarray or lysate microarray. In contrast to antibodies, which must be labeled after purification, 
aptamers can be labeled during their synthesis in a site-specific manner. This circumvents possible 
uncontrolled losses of function during labeling. In comparison to antibodies, which are usually applied 
as the recognition element, aptamers feature a higher signal to noise ratio and an improved limit of 
detection [8]. Besides these advantages of aptamer-based reverse phase microarrays, their applicability 
is rather limited. When spotting a complex sample containing only a small portion of the target to be 
analyzed, this target has to compete with other proteins for free immobilization sites on the 
microarray s´ surface. Consequently, only small amounts of the target are immobilized resulting in low 
signals and low sensitivity of the microarray, especially when complex samples are applied.  
2.5.3. Sandwich 
A sandwich microarray is a modified forward phase microarray in which the analyte is not labeled 
by itself, but addressed by another aptamer carrying the label for detection. However, to perform an 
assay of this type, the bound target has to display a second epitope, and even more importantly, two 
aptamers binding to different epitopes of the target have to be available. 
In comparison to a reverse phase microarray, this approach is more sensitive [10]. During the 
incubation of the sample the analyte is captured by the aptamer and therefore concentrated within the 
spot. The loading of the analyte within the spot is much higher in a sandwich assay, because in a 
reverse phase microarray mostly complex samples are immobilized, while in the sandwich format the 
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target is affinity purified by the immobilized aptamer. Furthermore, a sandwich assay exhibits higher 
specificity than an assay with a single affinity ligand (including forward phase and reverse phase 
microarray), as the target must be recognized by two affinity ligands rather than by one to result in a 
signal. This also reduces problems that rise from analyte-complexes. 
2.6. Detection Methods 
To measure the aptamer target interaction different detection methods can be applied to aptamer 
microarrays. The most common methods are described in the following. 
2.6.1. Fluorescent Dye-Based 
Like in classic DNA microarrays, fluorescent dyes can be applied in aptamer microarrays, as 
aptamers can be labeled site specifically with dyes during their synthesis; this simplifies setting up a 
reverse phase or sandwich aptamer microarray. When performing a forward phase microarray the 
analyte has to be labeled. Depending on the substance, modern coupling chemistry provides a versatile 
toolbox for attaching a fluorescent dye to a given target. The use of a fluorescent dye therefore is 
compatible with all assay formats. The easy access to fluorescent conjugates and the fact that the 
required instrumentation for detection is the same as in conventional microarrays make this the most 
frequently used detection method (see Table 2). 
In a forward phase microarray, the targets (mostly proteins) are often labeled before incubation with 
the aptamer microarray. The excessive unreacted dye is then removed and the target/dye ratio is 
determined as this ratio is an important parameter, which significantly affects the microarray 
performance. If the ratio is too low, this will result in low feature signal. On the other hand, extensive 
labeling may result in targets whose epitopes are masked by the label and therefore may not be 
recognized by the aptamer anymore [10,39]. To circumvent this limitation, staining can be done after 
capture with a fluorescent reagent specific for a class of targets (e.g., universal protein stain [40,41]). 
It should be noted that the fluorescence scanner and the scanning settings have a significant impact 
on the resulting statistic variations and microarray performance [42]. 
2.6.2. SPRi 
Surface plasmon resonance (SPR) has been extensively used to determine kinetics and binding 
affinities. Due to further development of this technology, it also possible to measure the resonance at 
each place within a whole chip in real time (surface plasmon resonance imaging (SPRi)). As a 
consequence, these chips can serve as substrates for multiplex analysis and can be applied to aptamer 
microarrays as well. This method is suitable for any assay format, as the measuring principle does not 
require a label, neither on the target nor on the aptamer. However, for a measurement either the 
aptamer or the target has to be immobilized on the chip surface. Due to matrix effects and leakage of 
molecules immobilized by adsorption, the baseline may shift during the measurements [43]. 
Furthermore, detection of small molecules is challenging as they generate only a small signal [44]. 
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2.6.3. Other 
Beside the methods described above, microarrays can also be read by using a radiolabel, via  
electro-chemical detection [6,45] or by matrix-assisted laser desorption/ionization (MALDI) mass 
spectrometry [46–48]. Furthermore, alternative label-free detection methods are emerging [49]. These 
methods have gained much attention as they do not require a label which would interfere in the folding 
of the aptamer or the interaction with the target. However, label-free detection relies on the intrinsic 
properties of an analyte. As there are many different techniques, label-free detection methods are 
reviewed elsewhere [50]. 
2.7. Applications of Aptamer Microarrays 
To date, aptamer microarrays are almost exclusively applied to proteins (see Table 2). The 
quantification of small molecules or toxins is still dominated by classic methods like HPLC or GC. As 
a substitute, aptasensors offer a rapid detection of a single analyte within the sample. However, 
multiplexed measurements of various proteins are of greater interest. Consistently, aptamer 
microarrays are currently focused on the quantification of proteins. Efficient immobilization and 
labeling technologies facilitate easy access to the microarray format.  
A novel application of aptamer microarrays is the investigation of protein-protein interactions 
(PPI) [38]. Here, immobilized aptamers are used to capture their target. The target is labeled and the 
given signal is used as a control. Then, a complex protein sample (e.g., cell lysate) with a different 
label is incubated with the microarray. In case of a protein-protein interaction the second label can be 
detected on the feature after the washing steps. 
Another promising field of application for aptamer microarrays is medicine. SomaLogic has 
developed different enhanced aptamer microarrays for the discovery of potential biomarkers and has 
demonstrated their successful use [51,52]. In the future aptamer microarrays may also be used to 
analyze patient samples on the presence or elevated levels of biomarkers [47,53].  
Furthermore, microarrays offer new possibilities for the evaluation and selection of aptamers. 
Microarrays have been used to analyze aptamer candidates which have been isolated in a SELEX 
procedure [39]. Several immobilized aptamer candidates are incubated with labeled target, and the 
affinity of the candidates is estimated by the resulting signal. In addition, this approach can be used to 
determine the binding site of an aptamer by immobilizing and assaying different truncated variations 
of this aptamer [54–56]. It is also possible to optimize a given aptamer by generation and 
microarray-assisted evaluation of mutated sequences [57]. Furthermore, the complete selection of an 
aptamer can be performed on chip as has been demonstrated by Knight et al. [58] and Platt et al. [59]. 
First, a library of randomized sequences was generated in silico, which then was synthesized on a 
microarray at distinct places. After the microarray was incubated with a given target, the binding on 
each feature was measured and new sequences for the next selection round were generated via a 
genetic algorithm. In this way aptamers with high affinities were generated (approx. 1.7–5.0 nM [58]; 
24 nM respectively [59]). 
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Table 2. Overview of aptamer microarray publications. 
Target Name Assay-Format Multiplexing Detection technique Limit of detection Author + Year 
Toll-like receptor 2 forward 
 
fluorescence scanner 
 
Chang 2009 [54] 
Thrombin/ E. coli total protein forward 12 fluorescence scanner 
 
Chen 2013 [38] 
Human Thrombin/VEGF forward 2 SPR 
 
Chen 2012 [60] 
4 different proteins forward 2 × 2 fluorescence scanner pM–nM Cho 2006 [10] 
Human angiopoietin-2 forward 15.000 fluorescence scanner 
 
Cho 2013 [61] 
Lysozyme; IgE forward 4 fluorescence scanner 70 fM; 5.2 fM Collett 2005 [62] 
Lysozyme forward 26 fluorescence scanner 70 fM Collett 2005 [39] 
Thrombin forward 
 
SPR 100 pM Daniel 2013 [63] 
IgE forward 15.000 fluorescence scanner 
 
Fischer 2008 [55] 
Streptavidin forward yes (?) fluorescence scanner 
 
Franssen-van Hal 2013 [9] 
Thrombin forward 2 fluorescence scanner 30–50 pM Lao 2009 [35] 
human fIXa forward 5 SPR 10 nM Li 2006 [64] 
4 different proteins forward 4 fluorescence polarization 
 
McCauley2003 [65] 
Thrombin forward 4.6 × 104 fluorescence scanner 
 
Platt 2009 [57] 
PFEI-His forward 
 
fluorescence scanner 
 
Sinitsyna 2012 [28] 
BGL-His + streptavidin forward 
 
fluorescence scanner 
 
Walter 2008 [30] 
IgE; IgG forward 
 
SPRi 2 nM Wang 2007 [66] 
PFEI-His forward 
 
fluorescence scanner 
 
Zhu 2011 [36] 
17 different proteins forward/heterogenic sandwich 17 fluorescence scanner pM–nM Bock 2004 [41] 
Thrombin forward/sandwich  resonance waveguide diffraction; fluorescence reader  Edwards 2010 [27] 
IgE heterogenic sandwich 
 
SPR 1 fM Kim 2010 [67] 
Thrombin / VEGF heterogenic sandwich 4 + 1 Control SPR 1 pM (VEGF) Li 2007 [68] 
PFEI-His reverse 
 
fluorescence scanner 30 nM Lübbecke 2012 [8] 
HCVNS3 protein reverse 
 
confocal laser scanning microscope 73 pM Roh 2010 [69] 
Yeast TBP (TATA Binding Protein) sandwich 
 
fluorescence scanner nM–µM Ahn 2010 [47] 
Thrombin sandwich 
 
fluorescence scanner 64 pM Edwards 2010 [70] 
Thrombin sandwich 
 
fluorescence scanner 0.17/0.75 nM Meneghello 2012 [71] 
8 different proteins sandwich 8 dual laser flow system; fluorescence 1–100 pM Ochsner 2014 [72] 
C-reactive protein (CRP) sandwich 
 
fluorescence scanner 43 pM Pultar 2009 [29] 
Thrombin + VEGF sandwich 2 fluorescence scanner 50 nM Sosic 2013 [73] 
Thrombin sandwich 
 
fluorescence scanner 
 
Sosic 2011 [74] 
Thrombin sandwich 
 
fluorescence microscope 0.27 nM Tennico 2010 [75] 
Ethanolamine pseudo-sandwich (TID)  fluorescence scanner 10 pM Heilkenbrinker 2014 [76] 
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2.8. Current Limitations and Future Prospects 
Many experiments have been performed to show that aptamers can be applied successfully within 
different microarrays formats (Table 2). Furthermore, there are very few commercial versions of 
aptamer microarrays available already (SOMAscan™). New detection techniques are emerging and 
current technologies are further developed to allow multiplexed analysis. However, there is still a lack 
of aptamers that are suitable for microarrays. While aptamers with rather high KD (in µM rage) have 
been successfully used in different applications like affinity separation [5,77], aptamer microarrays 
require aptamers with low binding constants [41]. Also the aptamer target complex should be slow 
dissociating [78]. This is especially important for microarrays, as an extension of washing  
steps can increase the signal to noise ratio but excessive washing should not result in a loss of  
aptamer-target complex. 
Other issues are associated with the applied assay conditions, as many of the aptamers have been 
selected by different scientists and under different conditions. Therefore, different aptamers require 
different buffers, additives, ions and ion strengths for their correct folding and function [10,70]. Trying 
to assemble a multiplex microarray by matching these requirements is quite challenging. When 
selecting aptamers that should be active together, it is best to select them under the same conditions. 
In a sandwich microarray, aptamers are required which bind to different epitopes of the target as the 
target is addressed by two aptamers. Aptamer pairs that exhibit this behavior may be found by 
incident. As a more constructive approach, adapted SELEX procedures have been developed to select 
aptamer pairs which address different epitopes [79]. 
Especially in the context of protein detection, aptamer microarrays have to compete with  
well-characterized antibody microarrays. In comparison to antibodies, aptamer technology is relatively 
new. The industry has put lots of efforts and money into the development of antibodies for the most 
important targets. Selecting aptamers against these targets would be a great outlay resulting in 
additional resistance to novel aptamer-based techniques. 
Microarrays for the detection of proteins are therefore largely dominated by antibodies. However, 
the use of antibodies for the detection of small molecules is limited as the generation of an antibody for 
a small molecule is difficult, since the target has to be immunogenic and must only exhibit a moderate 
toxicity. Furthermore, antibodies are about six times bigger than aptamers and cannot be used in 
sandwich assays for small molecules, which do not provide enough surface area for the simultaneous 
binding of two antibodies. On the other hand, it is possible to isolate aptamers against nearly any given 
target. Therefore aptamers can also be generated against small molecules, which are not immunogenic. 
Although some general problems arise when selecting an aptamer against a small targets, including the 
change of the target structure during immobilization and difficulties in determination of binding 
constants, aptamers have already been selected against a broad range of different small molecules [80]. 
New SELEX techniques like Capture SELEX allow for the screening of aptamers against small 
molecules without the need to immobilize the target. This has been recently demonstrated by Strehlitz 
and coworkers by the selection of aptamers targeting antibiotics [81]. These new techniques can be 
expected to further accelerate the use of aptamers in the context of small molecule detection. 
When applying classic microarray formats to small molecules using aptamers, some critical aspects 
have to be considered. If performing a forward phase assay the target has to be labeled. This may cause 
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problems because the overall molecular structure is significantly changed by labeling a small molecule 
with another molecule with equal or greater size. In a reverse phase microarray, the small target 
molecules have to be immobilized, which may also cause problems in subsequent aptamer binding. 
As a sandwich microarray would grant a label-free detection, it would therefore be a good 
alternative for small molecules. But aptamers often enclose their small molecule target by folding 
“around” it. The target would not display a second epitope for the second aptamer. In this case—as 
already described for antibodies—a sandwich assay is not possible.  
In this context, aptamers offer new assay designs, which could not be realized with antibodies, to 
overcome these limitations. Target-induced dissociation of complementary oligonucleotides (TID) can 
be used to detect small molecules with an aptamer microarray [6,76]. A fluorescent-labeled antisense 
oligonucleotide is hybridized to an immobilized aptamer prior to the incubation with the target. The 
fluorescence of the feature is measured. In presence of the target, the aptamer oligonucleotide hybrid 
dissociates, the antisense oligonucleotide is replaced by the target and the fluorescence of the feature is 
therefore lowered. We have recently demonstrated the applicability of TID for microarray-based 
detection of small molecules using an aptamer directed against ethanolamine. This strategy resulted in 
an excellent sensitivity (LOD = 10 pM) [76]. 
Another detection mechanism that could be useful in the aptamer-based detection of small 
molecules is target-induced structure switching (TISS) of aptamers [6]. During the binding of a target, 
an aptamer undergoes conformal changes. These changes may be measured by electrochemical 
detection or in an aptamer beacon format. In the latter, a fluorophore and a quencher are attached to the 
aptamer. Depending on the mode of the beacon, conformal changes may either approximate or depart 
the fluorophore and the quencher. In this way a measurable signal is generated with only one aptamer. 
While until now TISS-based detection was only performed in solution, it could also be transferred to 
microarray surfaces. 
A different option for small molecule detection may be the target-induced reassembly (TIR) of 
aptamers [6]. Here an aptamer fragment could be immobilized on the microarray surface. The 
microarray is then incubated with a mixture of the sample and a solution containing the second 
fragment of the aptamer. In presence of the target a complex of the two aptamer fragments and the 
target is formed. This pseudo-sandwich assay seems to be especially advantageous for the detection of 
small molecules. Although this principle has only been applied on a bead matrix, it is a promising 
approach for the detection of small molecules, which should be further investigated. 
3. Conclusion and Outlook 
It has been demonstrated that aptamers have been successfully applied as affinity ligands in many 
different techniques. Here, aptamers exhibit a high affinity and specificity. Aptamers can be selected 
against virtually any given target. Furthermore, automated and high throughput selection strategies and 
platforms have been developed to overcome the lack of suitable aptamers for a variety of different 
applications. Due to their chemical synthesis aptamers are relatively cost-efficient and show minimal 
batch-to-batch variations. Therefore, well-selected aptamers are valuable and reliable affinity ligands. 
Aptamers also allow highly multiplexed analysis, if the aptamers are selected under the same 
conditions. As a consequence, aptamers show great potential in microarray development.  
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To date aptamer microarrays are focused on the detection of proteins, but alternative assay formats 
also allow the detection of small molecules. Therefore, aptamer microarrays could be especially useful 
in the detection and quantification of small molecules. We expect them to become powerful tools 
for the easy and multiplexed profiling of small molecules, thereby opening up new applications, 
including metabolomics. 
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